Skip to main content

Table 3 Association between MLKL and clinicopathological characteristics of cancer patients

From: Prognostic and clinicopathological significance of MLKL expression in cancer patients: a meta-analysis

Clinicopathological parameters Studies (n) Patients (n) OR (95% CI) p value Heterogeneity
I2 (%) p Model
Differentiation grade (poorly and moderately VS well) 2 252 0.86 (0.16–4.57) 0.857 69.2% 0.071 Random
Gender (male vs. female) 2 252 1.41 (0.85–2.36) 0.188 0% 0.609 Fixed
Lymph node metastasis (yes vs. no) 4 380 3.83 (2.29–6.40) < 0.001 0% 0.478 Fixed
Tumor stage (III–IV vs. I–II) 3 326 1.81 (1.09–3.01) 0.021 21.7% 0.279 Fixed
Age (> 60vs. ≤ 60 years) 3 406 1.93 (1.28–2.93) 0.002 0% 0.569 Fixed
\